Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/de-gruyter/assessment-of-the-impact-of-the-covid-19-pandemic-on-the-financial-d0zkdsUXOU
- Publisher
- de Gruyter
- Copyright
- © 2022 Ioan Bircea et al., published by Sciendo
- eISSN
- 2668-3989
- DOI
- 10.2478/amso-2022-0005
- Publisher site
- See Article on Publisher Site
Abstract
AbstractThe financial performance of a commercial company is dependent on a multitude of factors, which can be grouped into external factors and internal factors. Through the conducted study, we tried to analyze the influence of external factors specific to the period of the COVID-19 pandemic, on the financial performance of some commercial companies in the field of manufacturing pharmaceutical products in Romania (Antibiotice) pharmaceutical preparations (Biofarm, Zentiva) ambulatory healthcare activity (Med Life). These commercial companies faced the conditions of the COVID-19 pandemic period, the measures taken in this regard, as well as the fierce competition from some international manufacturers (Sanofi, Sandoz Romania, Hoffmann la Roche, Pfizer, etc.). Thus, some commercial companies in the field of manufacturing pharmaceutical products have reduced their volume of activity and others have performed much higher than the pre-pandemic period.
Journal
Acta Marisiensis Seria Oeconomica – de Gruyter
Published: Jun 1, 2022
Keywords: performance; COVID-19; pharmaceutical; rate of return